![Rational use of inhaled corticosteroids for the treatment of COPD | npj Primary Care Respiratory Medicine Rational use of inhaled corticosteroids for the treatment of COPD | npj Primary Care Respiratory Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41533-023-00347-6/MediaObjects/41533_2023_347_Fig1_HTML.png)
Rational use of inhaled corticosteroids for the treatment of COPD | npj Primary Care Respiratory Medicine
![Inhaled Corticosteroid Treatment in Chronic Obstructive Pulmonary Disease ( COPD): Boon or Bane? | American Board of Family Medicine Inhaled Corticosteroid Treatment in Chronic Obstructive Pulmonary Disease ( COPD): Boon or Bane? | American Board of Family Medicine](https://www.jabfm.org/content/jabfp/33/2/289/F2.large.jpg?width=800&height=600&carousel=1)
Inhaled Corticosteroid Treatment in Chronic Obstructive Pulmonary Disease ( COPD): Boon or Bane? | American Board of Family Medicine
American College of Chest Physicians - In a real-world setting, LAMA-LABA-ICS is as effective as LAMA-LABA to prevent COPD exacerbations, but incidence of pneumonia increased with triple therapy initiation: https://hubs.ly/H0pPLQ20 | Facebook
![Effectiveness of Treatment With Dual Bronchodilation (LABA/LAMA) Compared With Combination Therapy (LABA/ICS) for Patients With COPD: A Population-Based Study | Archivos de Bronconeumología Effectiveness of Treatment With Dual Bronchodilation (LABA/LAMA) Compared With Combination Therapy (LABA/ICS) for Patients With COPD: A Population-Based Study | Archivos de Bronconeumología](https://static.elsevier.es/multimedia/03002896/0000005800000010/v2_202302271800/S0300289622003374/v2_202302271800/en/main.assets/gr1.jpeg)
Effectiveness of Treatment With Dual Bronchodilation (LABA/LAMA) Compared With Combination Therapy (LABA/ICS) for Patients With COPD: A Population-Based Study | Archivos de Bronconeumología
![Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study - The Lancet Respiratory Medicine Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/attachment/cf7c63e7-298c-40aa-ace2-39bf59630ff1/gr1.gif)
Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study - The Lancet Respiratory Medicine
![Figure 2 from LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes | Semantic Scholar Figure 2 from LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/410388bf4ca6316b0fbca72a61ab191f5ae501af/7-Figure2-1.png)
Figure 2 from LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes | Semantic Scholar
![Is aclidinium alone or combined with a LABA a rational choice for symptomatic COPD patients? | Respiratory Research | Full Text Is aclidinium alone or combined with a LABA a rational choice for symptomatic COPD patients? | Respiratory Research | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12931-017-0506-0/MediaObjects/12931_2017_506_Fig3_HTML.gif)
Is aclidinium alone or combined with a LABA a rational choice for symptomatic COPD patients? | Respiratory Research | Full Text
![PDF] LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes | Semantic Scholar PDF] LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/410388bf4ca6316b0fbca72a61ab191f5ae501af/4-Figure1-1.png)